
HTF Market Intelligence published a new research publication on Asthma And Copd Drugs Market Insights, to 2028" with 150+pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Asthma And Copd Drugs market was mainly driven by the increasing R&D spending across the world, however latest scenario and economic slowdown have changed complete market dynamics. Some of the key players profiled in the study are Hoffmann-La Roche Ltd (Switzerland), Teva Pharmaceutical Industries Ltd (Israel), Boehringer Ingelheim International GmbH (Germany), Glaxosmithkline Plc (United Kingdom), Organon (United States), Novartis AG (Switzerland), Sanofi (France), AstraZeneca Plc (United Kingdom), Vectura Group Plc (United Kingdom), Abbott Laboratories (United States), Merck & Co Inc (United States), Pfizer Inc. (United States), Cipla Inc. (India), Glenmark Pharmaceuticals (India), Astellas Pharma (Japan), Others